Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 720 of 767

Advanced search

🌍Apr 18, 2017Industryimmutep.comTier 1 · Company source

Prima BioMed Receives Approval for Third Cohort of Phase I Melanoma Trial - Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

ImmutepOriginal source

🌍Apr 12, 2017Industryimmutep.comTier 1 · Company source

Prima BioMed receives A$492,144 Tax Refund from Australian Government - Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

ImmutepOriginal source

🇹🇷Apr 4, 2017Regulatoryaifd.org.trTier 1 · Regulatory source

Yenilikçi İlaçlar

AIFD TurkeyOriginal source

🇹🇷Apr 4, 2017Regulatoryaifd.org.trTier 1 · Regulatory source

Doktorunuzla Görüşme Öncesi ve Sonrası Hazırlıklarınızı Yapmayı Unutmayın!

AIFD TurkeyOriginal source

🇹🇷Apr 4, 2017Regulatoryaifd.org.trTier 1 · Regulatory source

Akılcı İlaç Kullanımı

AIFD TurkeyOriginal source

🌍Mar 16, 2017Industryimmutep.comTier 1 · Company source

Prima BioMed Completes Recruitment for Second Patient Cohort in Melanoma Trial and Will Present at ICI Conference in Boston - Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

ImmutepOriginal source

🇹🇷Mar 2, 2017Regulatoryaifd.org.trTier 1 · Regulatory source

Kullanım Talimatını Tanıyalım

AIFD TurkeyOriginal source

🌍Mar 2, 2017Industryimmutep.comTier 1 · Company source

USA Patent Grants for IMP321 in Cancer - Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

ImmutepOriginal source

🇹🇷Mar 1, 2017Regulatoryaifd.org.trTier 1 · Regulatory source

Hasta Hakları ve Sorumlulukları

AIFD TurkeyOriginal source

🌍Feb 25, 2017Industryimmutep.comTier 1 · Company source

First Half 2017 Operational Update - Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

ImmutepOriginal source

🌍Feb 14, 2017Industryimmutep.comTier 1 · Company source

Prima BioMed Receives ~A$860,000 Tax Credit Payment from French Government - Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

ImmutepOriginal source

🌍Jan 24, 2017Industryimmutep.comTier 1 · Company source

Prima BioMed to Present at 2nd Annual Cancer Immunotherapy Conference - Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

ImmutepOriginal source

🌍Jan 21, 2017Industryimmutep.comTier 1 · Company source

Prima BioMed Commences Randomised Phase IIb Clinical Trial for IMP321 in Breast Cancer - Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

ImmutepOriginal source

🌍Jan 19, 2017Industryimmutep.comTier 1 · Company source

Prima BioMed to Maintain NASDAQ Listing - Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

ImmutepOriginal source

🌍Jan 13, 2017Industryimmutep.comTier 1 · Company source

Prima BioMed Commences Recruitment for Second Cohort of Melanoma Trial - Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

ImmutepOriginal source

🌍Jan 6, 2017Industryimmutep.comTier 1 · Company source

Prima BioMed enters new Material Transfer Agreement with Cytlimic - Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

ImmutepOriginal source

🌍Jan 3, 2017Industryimmutep.comTier 1 · Company source

Prima announces new Product Candidate IMP761 – a LAG-3 Agonist Antibody - Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

ImmutepOriginal source

🇩🇰Sep 15, 2016Industryserviersymphogen.comTier 3 · Secondary coverage

Symphogen Names New Chief Financial Officer

SymphogenOriginal source

🇩🇰Aug 18, 2016Industryserviersymphogen.comTier 3 · Secondary coverage

Symphogen’s founding CEO Kirsten Drejer steps down and becomes Executive Director

SymphogenOriginal source

🌍Oct 21, 2015Industryscripps.orgTier 1 · Company source

Can You Get a Mammogram with Breast Implants?

Scripps HealthOriginal source

🌍Jul 1, 2015Industryscripps.orgTier 1 · Company source

Heartburn or Heart Attack? How to Tell the Difference

Scripps HealthOriginal source

🌍Feb 10, 2015Industryscripps.orgTier 1 · Company source

Whooping Cough vs Cold: How to Tell the Difference

Scripps HealthOriginal source

🇧🇪Sep 12, 2011Regulatoryfamhp.beTier 1 · Regulatory source

« Un médicament n’est pas un bonbon ! »

FAMHP (Belgium)Original source

🇧🇪Oct 12, 2010Regulatoryfamhp.beTier 1 · Regulatory source

"Miracle Mineral Solution" or "MMS": warning

FAMHP (Belgium)Original source

🇧🇪Jan 1, 2009Regulatoryfamhp.beTier 1 · Regulatory source

@ctua 1/4 2009

FAMHP (Belgium)Original source

🇧🇪Jan 1, 2008Regulatoryfamhp.beTier 1 · Regulatory source

@ctua 1/4_2008

FAMHP (Belgium)Original source

🇪🇬Oct 14, 1790Industrydeltapharma.comTier 1 · Company source

Fi Europe 2026: ¡nos vemos en Frankfurt!

Delta PharmaOriginal source

🇪🇬Oct 1, 1785Industrydeltapharma.comTier 1 · Company source

CPHI 2026: nos vemos en Milán

Delta PharmaOriginal source

🇪🇬Oct 1, 1778Industrydeltapharma.comTier 1 · Company source

Nimesulida: asegura tu suministro

Delta PharmaOriginal source

🇪🇬Oct 1, 1777Industrydeltapharma.comTier 1 · Company source

Xilitol: optimiza tu sourcing

Delta PharmaOriginal source

🇪🇬Oct 1, 1771Industrydeltapharma.comTier 1 · Company source

Vitafoods Europe 2026

Delta PharmaOriginal source

🇪🇬Oct 1, 1756Industrydeltapharma.comTier 1 · Company source

Encuéntranos en CPHI Worldwide

Delta PharmaOriginal source

🇪🇬Jul 28, 1756Industrydeltapharma.comTier 1 · Company source

Próximas Ferias 2025

Delta PharmaOriginal source

🇪🇬Oct 1, 1751Industrydeltapharma.comTier 1 · Company source

Better Stands: ¡Bronce conseguido!

Delta PharmaOriginal source

🇪🇬Apr 8, 1750Industrydeltapharma.comTier 1 · Company source

Eggshell power, alivio articular

Delta PharmaOriginal source

🇪🇬Jan 24, 1750Industrydeltapharma.comTier 1 · Company source

Kalita®: bienestar cardiometabólico

Delta PharmaOriginal source

🇪🇬Oct 1, 1748Industrydeltapharma.comTier 1 · Company source

Salud de las piernas

Delta PharmaOriginal source

🇪🇬Jan 31, 1747Industrydeltapharma.comTier 1 · Company source

Dos aliados naturales para el bienestar digestivo

Delta PharmaOriginal source

🇪🇬Oct 1, 1744Industrydeltapharma.comTier 1 · Company source

¡Nos vemos en Vitafoods!

Delta PharmaOriginal source

🇪🇬Jul 2, 1744Industrydeltapharma.comTier 1 · Company source

BROMEYAL®: Enzimas Proteolíticas

Delta PharmaOriginal source

🇪🇬Oct 1, 1743Industrydeltapharma.comTier 1 · Company source

Mejora la movilidad con Axtragyl®

Delta PharmaOriginal source

🇪🇬Oct 1, 1742Industrydeltapharma.comTier 1 · Company source

Okara, el Ingrediente del Futuro

Delta PharmaOriginal source

🇪🇬Dec 6, 1721Industrydeltapharma.comTier 1 · Company source

CPHI 2024 en Milano

Delta PharmaOriginal source

🇪🇬Jan 31, 1717Industrydeltapharma.comTier 1 · Company source

Ingredientes para piensos

Delta PharmaOriginal source

🌍Jan 1, 1970Industryxbiotech.comTier 1 · Company source

From Lab to Cover: XBiotech Scientists Earn Cover Recognition in the Texas Journal of Microscopy

XBiotechOriginal source

🌍Jan 1, 1970Industryxbiotech.comTier 1 · Company source

XBiotech Scientists Demonstrate Therapeutic Potential of IL-1α Blockade in Pulmonary Melanoma

XBiotechOriginal source

🌍Jan 1, 1970Industryxbiotech.comTier 1 · Company source

XBiotech Has Non-clinical Data for a Novel Shingles Therapy Ready for IND Submission

XBiotechOriginal source

🌍Jan 1, 1970Industryxbiotech.comTier 1 · Company source

XBiotech Awarded Three U.S. Patents Protecting Next-Generation True Human™ Antibodies Targeting Interleukin-1 Alpha

XBiotechOriginal source

🌍Jan 1, 1970Industryxbiotech.comTier 1 · Company source

Phase II Portion for Natrunix™ Trifluridine/Tipiracil (TASKIN) Study Ongoing

XBiotechOriginal source

🌍Jan 1, 1970Industryxbiotech.comTier 1 · Company source